top of page

Minimally Invasive Glaucoma Surgery

MIGS procedures constitute a group of surgical interventions which share five characteristics:
 

  1. High safety profile: MIGS carry a much lower risk of serious complications such as hypotony, choroidal effusions, or choroidal hemorrhages.
     

  2. Minimal disruption of normal anatomy: MIGS allow for enhancement of physiological outflow mechanisms avoiding major alterations in normal ocular anatomy.
     

  3. Ab interno approach: MIGS are typically performed ab interno through a traditional clear corneal wound with direct visualization of the anatomical target. 
     

  4. Efficacy: MIGS should offer meaningful IOP lowering effect. The level of IOP reduction is often inferior to traditional filtering surgery but should be at least 20%.  Alternatively, patients who do not experience an IOP decrease should attain the reduction of at least one medication.
     

  5. Ease of use for patients and physicians: MIGS should allow for a rapid recovery with minimal additional downtime for patients.  They should also be easily incorporated into traditional phacoemulsification surgery.

OMNI
Surgical System

The Omni Surgical System allows your surgeon to do two implant free procedures with one device; the first is a Canaloplasty and the second is a Trabeculotomy.  The Omni is a safe and effective way to help patients treat glaucoma that is progressing or help patients who have stable glaucoma come off one or two glaucoma medications.  The Omni is FDA approved to be done in conjunction with cataract surgery or as a standalone procedure.  As shown in the video below a microcatheter is used to canulate the drainage system (schlemm's canal) in the eye which dilates the drainage angle and allows the aqueous humor to flow out of the eye more readily therefore allowing the eyes introcular pressure to be reduced.  

Hydrus Microstent

The hydrus microstent is a device that is implanted into the drainage angle of the eye to enhance the natural outflow of the aqueous humor helping to reduce the eye pressure.  This device spans 90 degrees of the drainage angle which makes it the largest and most effective implantable MIGS device.  The hydrus microstent is only FDA approved for placement in conjunction with cataract surgery.  This device is not FDA approved as a standalone procedure.  

bottom of page